Abstract:Background: Gram-negative bacilli are one of the most common causes of various infections in clinical. The emergence and global spread of multi-drug resistant gram-negative bacilli has become a major challenge in the global public health field. Methods: A total of 51,189 non-repetitive strains of gram-negative bacilli were isolated in clinical settings. The antimicrobial susceptibility testing was conducted by using the automated VITEK 2 compact system and the matched AST susceptibility test card, complemented by the disk diffusion method. The antimicrobial susceptibility results were interpreted by CLSI. Rates of MDR and XDR in Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were investigated. Used the chi-square test to determine whether the antimicrobial resistance rates of four major gram-negative bacilli isolated from ICU and non-ICU department have statistical differences. Results: Escherichia coli (31.4%), Klebsiella spp. (21.2%), Acinetobacter spp. (13.8%), and P. aeruginosa (11.0%) were the most frequently isolated gram-negative bacilli. Escherichia coli was the top one organism isolated from urinary tract (68.4%), bloodstream (39.9%), body fluid (33.2%), wound and pus (37%), except for respiratory tract (8.8%). Whereas Acinetobacter baumannii and K. pneumoniae were the major isolated organisms from respiratory tract. Acinetobacter baumannii showed high resistance to fluoroquinolones, β-lactam/β-lactamase inhibitor combinations class, ceftazidime, cefepime, imipenem, and meropenem, the resistance rates reached more than 70%. Ceftazidime showed a lower resistance rate to E. coli than ceftriaxone. For E. coli , fluoroquinolones showed a high resistance rate (ciprofloxacin 61.36% and levofloxacin 53.97%), whereas amikacin, carbapenems exhibited a lower resistance rate fluctuating at 2%. Acinetobacter baumannii and K. pneumoniae showed rapid increases in carbapenem resistance whereas E. coli had the lowest resistance rate and remain stable at 2%. Acinetobacter baumannii exhibited the highest rate of MDR and XDR, reaching 60–80 and 45–55%, respectively. Compared to non-ICU departments, the resistance rates of four major gram-negative bacilli in the ICU department were much higher and the differences were statistically significant ( p < 0.05). Conclusion: Amikacin, carbapenems, and piperacillin/tazobactam exhibited relatively high sensitivity, whereas fluoroquinolones showed high resistance rate whether they can be the first-line antimicrobials for empirical treatment of UTI should take more consideration. The gram-negative bacilli in ICU were more resistance than that in non-ICU. These findings are helpful for clinicians using antimicrobials reasonably.

Four-Year Continuous Inspect of Activity of Ciprofloxacin on Gram-Negative Bacilli

Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014

An analysis on antibacterial drug use and drug resistance of Gram-negative bacilli from 2002 to 2005

[Surveillance of Antimicrobial Resistance among Nosocomial Gram-Negative Pathogens from 15 Teaching Hospitals in China in 2005].

Resistance of Clinical Isolated Gram Negative Bacilli to Tigecycline

Repeated Treatments of Ciprofloxacin and Kresoxim-Methyl Alter Their Dissipation Rates, Biological Function and Increase Antibiotic Resistance in Manured Soil.

Clinical Distribution and Drug Resistance of 4 Non-Fermenting Bacteria of Lower Respiratory Tract Infection

Exploring Microbial Community Structure and Biological Function in Manured Soil During Ten Repeated Treatments with Chlortetracycline and Ciprofloxacin.

Development of Antibiotic Resistance Genes in Soils with Ten Successive Treatments of Chlortetracycline and Ciprofloxacin

Monitoring of antimicrobial resistance in gram-negative bacilli isolated from lower respiratory tract of patients for 3 consecutive years

[Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)]

Surveillance of Gram-negative bacterial resistance: data from Ministry of Health P. R. China National Antibacterial Resistance Investigation Net in 2004-2005

Dynamic Monitoring of Distribution and Antibiotic Resistance of Common Gram-Negative Bacilli

Changing pattern of bacterial resistance in Gram negative bacilli

Pharmacokinetic-pharmacodynamic analysis of ciprofloxacin in elderly Chinese patients with lower respiratory tract infections caused by Gram-negative bacteria.

Analysis of Bacterial Drug Resistance Changes in Our Hospital During 2001～2005

Diversity of Antimicrobial Resistance among Gram-negative bacilli

Comparison of antibacterial activities of cefepime and 4 others antibiotics against gram-negative Bacilli isolated

Changes of Pathogens and Antimicrobial Resistance of Nonfermenting Gram-negative Bacilli in Intensive Care Unit

In-vitro activity of levofloxacin against bacterial pathogens collected in China：A ten-year（2009-2018） retrospective study

Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021